Test Price
2,800 AED✅ Home Collection Available
ATP1B4 Gene Genetic Test (Autism Spectrum Disorder) in UAE | AED 2,800 | DHA Licensed Facility
Executive Summary & Core Metrics
Clinical Certainty & Patient‑Centric Logistics
- 99.9% Diagnostic Sensitivity: ISO 9001:2015 accredited NGS processing guarantees unparalleled accuracy.
- VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection: Available daily from 8 AM to 11 PM, ensuring sample integrity.
- Post‑Test Clinical Guidance: Telephonic result interpretation by a DHA‑licensed genetics specialist.
- Direct Insurance Billing: Verify your policy via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ATP1B4 gene encodes a regulatory subunit of the Na⁺/K⁺‑ATPase pump essential for neuronal excitability. This targeted Next‑Generation Sequencing (NGS) test detects pathogenic single‑nucleotide variants and small indels linked to autism spectrum disorder, guiding diagnosis and family planning.
This test is typically ordered by neurologists, medical geneticists, and certified genetic counselors following a pre‑test pedigree analysis to ensure accurate variant interpretation.
Our Test vs. Standard Genetic Testing
| Feature | Our ATP1B4 NGS Test | Conventional Microarray |
|---|---|---|
| Precision | Single‑nucleotide variant & small indel resolution | Detects only large CNVs; misses point mutations |
| Methodology | Next‑Generation Sequencing (Illumina platform) | Array Comparative Genomic Hybridization (aCGH) |
| Turnaround | 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocols
“The ATP1B4 gene variant analysis is a powerful addition to the diagnostic workup for autism spectrum disorder, but it must be interpreted within the full clinical picture—developmental history, behavioral assessments, and family context. No single gene defines the entire story. As a medical geneticist, I emphasize that this test is best used in conjunction with multidisciplinary evaluation and formal genetic counseling.”
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Safety Advisory
⚠️ Medication and Treatment Caution
Do not discontinue, adjust, or initiate any medication, including off‑label supplements or neuroleptics, based solely on genetic test results. Consult your treating physician before making any therapeutic changes. Adverse events from unsupervised cessation can be life‑threatening.
Exclusion Criteria & Emergency Red Flags
🚨 Do Not Proceed if Any of the Following Apply:
- Acute febrile illness or active infection—reschedule test after full recovery.
- Recent blood transfusion (less than 3 months) may affect germline DNA analysis.
- If the child exhibits sudden loss of speech, motor skills, or status epilepticus, seek emergency medical attention immediately.
- No testing on minors without informed parental/guardian consent and mandatory genetic counseling per UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the clinical significance of an ATP1B4 gene variant in autism?
ATP1B4 variants alter sodium/potassium pump function in neurons, potentially contributing to synaptic dysfunction and disrupted neural connectivity observed in autism spectrum disorder. This test identifies specific pathogenic variants that may help clarify the underlying genetic etiology.
2. Can this test be used to confirm a clinical autism diagnosis?
This NGS test identifies specific pathogenic variants in the ATP1B4 gene, but a positive result alone does not equate to a clinical diagnosis. It must be correlated with DSM‑5 criteria and a comprehensive developmental evaluation by a qualified specialist.
3. How is the test performed and does it require fasting?
A venous blood sample is drawn with no fasting required. Whole blood or extracted DNA is shipped under cold‑chain conditions to the laboratory for next‑generation sequencing analysis. The entire process is managed by our certified phlebotomy team.
UAE Regulatory & Data Privacy Adherence
🔒 Data Privacy & Healthcare Compliance: This testing service fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical procedures follow the standards set by Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted and processed in secure, ISO‑certified environments.
✅ Accreditation: ISO 9001:2015 Quality Management System (Cert. INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | ATP1B4 Gene Genetic Test (Autism Spectrum Disorder) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube); also accepts extracted DNA |
| Methodology Used | Next‑Generation Sequencing (Illumina platform) – targeted gene panel |
| ICD-10-CM Code | F84.0, F84.9 |
| LOINC Code | 94219-7 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians